Search Results 481-490 of 3034 for 谷歌日本搜索引入口咨询邮箱：lgooxc@hotmail.com

  1. Evaluating an Interactive Medical Record Timeline (MeRLin) to Facilitate Historical Chart Review During New Patient Encounters in the ICU - Mayo Clinic

    Evaluating an Interactive Medical Record Timeline (MeRLin) to Facilitate Historical Chart Review During New Patient Encounters in the ICU · Overview.

  2. Low-Cost Tool for Compliance and Treatment-Tracking of Low Back Pain Patients - Mayo Clinic

    The purpose of this pilot phase study is to assess functionality and ease of use of an exercise monitoring system and decide whether any modifications are ...

  3. A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection - Mayo Clinic

    About this study. This is a randomized, controlled, parallel, multicenter study to determine the difference in post-operative anastomotic leak rate in low ...

  4. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    The purpose of this two-phase study is to compare CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monotherapy administered to ...

  5. A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy (X-TOLE) - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness, safety and tolerability of XEN1101 administered as adjunctive treatment in adult patients ...

  6. BinaxNow™ Rapid Test - Clinical Trials

    About this study. The purpose of this study is to validate the BinaxNOW™ COVID-19 Ag Card in the asymptomatic COVID-19 screening population.

  7. OPsumit USers Registry - Mayo Clinic

    About this study. Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) ...

  8. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    Dose escalation study to determine the maximum tolerated dose of NEOD001 in approximately 30 subjects with AL amyloidosis. Expansion phase to evaluate safety, ...

  9. Resources - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    National Human Genome Research Institute: Polygenic risk scores. CanRisk breast and ovarian cancer risk calculator. Publications. The eMERGE Network recommends ...

  10. A Study Of KK2269 In Adult Participants With Solid Tumors - Mayo Clinic

    Part 1 and Part 2 will be conducted as a multicenter, open-label, non-randomized, dose-escalation study. Participants with advanced or metastatic solid tumors ...